Changes in the value of goodwill by reportable segments were as follows:


	Year ended December 31, 2013
	U.S. dialysis and related lab services			HCP			Other ancillary services and strategic initiatives			Consolidated total
Balance at January 1, 2013	$	5,309,152		$	3,506,571		$	137,027		$	8,952,750
Acquisitions		163,037			17,833			90,397			271,267
Divestitures		(2,728	)		—			—			(2,728	)
Other adjustments		12			(8,242	)		(85	)		(8,315	)

Balance at December 31, 2013	$	5,469,473		$	3,516,162		$	227,339		$	9,212,974


	Year ended December 31, 2012
	U.S. dialysis and related lab services			HCP			Other ancillary services and strategic initiatives			Consolidated total
Balance at January 1, 2012	$	4,865,864		$	—		$	81,112		$	4,946,976
Acquisitions		443,997			3,518,790			88,611			4,051,398
Divestitures		(709	)		—			—			(709	)
Held for sale		—			—			(31,853	)		(31,853	)
Other adjustments		—			—			(843	)		(843	)

Balance at December 31, 2012 as previously reported	$	5,309,152		$	3,518,790		$	137,027		$	8,964,969
HCP purchase accounting adjustments		—			(12,219	)		—			(12,219	)

Balance at December 31, 2012 as adjusted	$	5,309,152		$	3,506,571		$	137,027		$	8,952,750